Aims: Diuretics are recommended for treating congestive symptoms in heart failure (HF). The short-and long-term prognostic effects of diuretic treatment at hospital discharge have not been studied in randomized clinical trials or in a Western world population. We aimed to determine the association of diuretic treatment at discharge with the risk of short- and long-termall-cause mortality in real-life patients in Sweden with HF irrespective of EF. Methods and results: From a Swedish nationwide HF register 26,218 patients discharged from hospital were included in the present study. A total of 87% of patients were treated with and 13% were not treated with diuretics at hospital discharge. In a 1:1 propensity score-matched cohort of 6564 patients, the association of diuretic treatment at hospital discharge with the risk of 90-day all-cause mortality was neutral (HR 0.89, 95% CI 0.74-1.07, p = 0.21) whereas the risk of long-term all-cause mortality (median follow-up: 2.85 years) was increased (HR 1.15, 95% CI 1.06-1.24, p amp;lt; 0.001). Conclusion: Diuretic treatment at hospital discharge was not associated with short-term mortality whereas it was associated with increased long-term mortality. Although we accounted for a wide range of clinical features, measured or unmeasured factors could still explain this increase in risk. However, our results suggest that diuretic treatment at hospital discharge may be regarded as a marker of increased long-term mortality. (C) 2017 The Authors. Published by Elsevier Ireland Ltd.
Funding Agencies|Swedish Research Council [340-2013-5187, 521-2013-4236]; Swedish Heart and Lung Foundation [20110155, 2015-0438]; Goteborg Medical Society [GLS-331961]; Swedish National Board of Health and Welfare; Swedish Association of local authorities and Regions; Swedish Society of Cardiology; [ALFGBG-427301]; [ALFGBG136761]